Read Time:7 Second
Johnson & Johnson has agreed to purchase Abiomed, a heart-device maker, for an initial $16.6 billion including cash in the deal.
Johnson & Johnson has agreed to purchase Abiomed, a heart-device maker, for an initial $16.6 billion including cash in the deal.
Average Rating
More Stories
NHL Games (3/27/2025)
NCAA Men’s Basketball Tournament (Night 1-Sweet 16 Round)
MLB: AL 2025 Preview